Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.

A simple and sensitive procedure is described for the quantitative determination of N-butyl-N-(3-carboxypropyl)nitrosamine (BCPN), the principal metabolite of the bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine (BHBN-4), in urine. BCPN was analyzed by gas-liquid chromatography as its methyl ester after extraction with ethyl acetate from urine followed by esterification with diazomethane. Species and strain variations in susceptibility to bladder carcinogenesis induced by BHBN-4 are discussed in relation to the urinary excretions of BCPN, determined by the new procedure, after oral administration of the compound to rats (4 strains), mice, hamsters, and guinea pigs at a dose approximately equal to the daily dose used in chronic carcinogenicity assay.

[1]  J. Aoki,et al.  Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis. , 1983, Gan.

[2]  T. Kakizoe,et al.  High susceptibility of analbuminaemic rats to induced bladder cancer. , 1982, British Journal of Cancer.

[3]  J. Aoki,et al.  Metabolic fate of N-butyl-N-(4-hydroxybutyl) nitrosamine and N, N-dibutylnitrosamine in the guinea pig, with reference to their carcinogenic effects on the urinary bladder. , 1981, Gan.

[4]  M. Okada,et al.  Metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat. , 1980, Gan.

[5]  M. Okada,et al.  Nuclear Magnetic Resonance Spectra of N-Alkyl-N-(ω-carboxyalkyl)-nitrosamines and Their Esters, and Chromatographic Separation of the (Z)-and (E)-Conformers of the Esters , 1980 .

[6]  S. Nagase,et al.  Albumin-deficient rat mutant. , 1979, Science.

[7]  M. Okada,et al.  Syntheses of N-alkyl-N-(omega-carboxyalkyl)nitrosamines related to N-butyl-N-(3-carboxypropyl)nitrosamine, principal urinary metabolite of a potent bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine. , 1978, Chemical and pharmaceutical bulletin.

[8]  M. Okada,et al.  Syntheses of N-alkyl-N-(hydroxy- or oxo-alkyl) nitrosamines related to N-butyl-N-(4-hydroxybutyl) nitroamine, a potent bladder carcinogen. , 1978, Chemical and pharmaceutical bulletin.

[9]  M. Okada,et al.  Metabolic fate of N-n-butyl-N-(4-hydroxybutyl)-nitrosamine and its analogues. Selective induction of urinary bladder tumours in the rat. , 1977, Xenobiotica; the fate of foreign compounds in biological systems.

[10]  M. Okada,et al.  Carcinogenicity of N-nitrosamines related to N-butyl-N-(4-hydroxybutyl)nitrosamine and N,N,-dibutylnitrosamine in ACI/N rats. , 1976, Gan.

[11]  M. Hirose,et al.  Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds. , 1976, Gan.

[12]  N. Ito,et al.  Effect of various factors on induction of urinary bladder tumors in animals by N-butyl-n-(4-hydroxybutyl)nitrosoamine. , 1973, Gan.

[13]  Y. Hashimoto,et al.  Induction of urinary bladder tumors in ACI-N rats by butyl(3-carboxypropyl)nitrosoamine, a major urinary metabolite of butyl-(4-hydroxybutyl)nitrosoamine. , 1972, Gan.